The research desk, productised
Our deal flow is already AI-heavy — and so is our diligence. The same tooling the team uses to screen raises is becoming a product suite: free to try, priced by depth, cheaper when paid in $BIOME.
Deal Analyzer
Launching soonPaste a project and get a structured research brief: team signals, token design, unlock schedule, red flags. The same first-pass screen our diligence desk runs — try it free, buy credits for depth.
Research Desk subscription
Launching soonWeekly deep-dive research notes on early-stage sectors and upcoming raises, written by the diligence team with AI leverage. Cancel anytime.
Member Copilot
Members betaAsk questions across NFC's research archive, deal terms and your own portfolio context. Depth and query limits scale with membership tier.
DD-as-a-Service
EnquireStructured due-diligence reports for funds, launchpads and projects — the pipeline that has screened 30+ raises, productised. White-label available.
Interested in DD-as-a-Service or white-label research? Email the desk.
Every member gets AI. Depth scales.
| Tier | AI access |
|---|---|
| Observer (free) | Analyzer free tier · public research summaries · deal notes by email |
| Voyager | Full analyzer credits monthly · Research Desk included 3 months · copilot standard |
| Vanguard | Higher limits · Research Desk included · copilot with portfolio context |
| Sovereign | Unlimited fair-use · analyst Q&A access · early tool releases |
All AI outputs are research and education. They are not investment advice, signals, or recommendations, and no tool manages money. Allocation decisions are always yours.
Try the analyzer first
Join the observer list and you'll get analyzer access the day it opens — free tier, no card.